MCC Update 3-19-13
Update is an official newsletter of the Masonic Cancer Center for faculty, members, staff, colleagues, and friends. All submissions for the next issue must be sent to Sandi Sherman, email@example.com, by noon on Friday for publication the following Tuesday.
March 19, 2013
Dear faculty and staff,
A newly redesigned Masonic Cancer Center website will be launched on Wednesday, March 20, 2013. The objective of the center’s website is to reflect the center’s science and resources internal and external to the center. Additionally the site will provide visitors with access to clinical cancer-related information provided by the university, AHC, the University of Minnesota Physicians, and the University of Minnesota Medical Center. The decision to revamp the website is the result of a number of factors, including:
- The need to have a website that reflects the comprehensive overview of the cancer center’s research, successes and plans for the future, as outlined in the Cancer Center Support Grant renewal application we have recently submitted.
- The current site, in addition to being outdated, is duplicative of information available on university, AHC and Fairview sites.
- There is a tremendous amount of confusion, particularly among patients, between the Masonic Cancer Center and the clinics. By focusing the Masonic Cancer Center’s site to our research, education and outreach missions, and directing patients to alternate sites for care information, we hope to alleviate this confusion.
- The current web site is on a platform that is no longer supported. Moving to the same platform that the Academic Health Center’s sites are currently using will mean that technical issues that arise in the future will be addressed by the AHC team.
Key changes include:
- New front page which assists visitors in finding the information and is flexible enough to update quickly
- Clinical care information is linked with UMMC to assist patients and families to more efficiently access the information they need.
- Faculty profiles are linked to their academic departments to avoid duplication of effort and the need for faculty to update multiple profiles to keep them current.
- Alignment of program descriptions with the write-ups that were submitted in the CCSG renewal applications
This is the first phase of the update, prioritizing the center’s research programs and shared resources. We continue to work on the site and look to you for feedback and content.
Please contact Mary Sumpmann and Sandi Sherman with comments and input.
Douglas Yee, M.D.
Director, Masonic Cancer Center
March 19, 2013, 12-1 p.m., 450 MCRB
Clinical perspectives for regulatory T cells in transplantation tolerance
Keli Hippen, Ph.D., Assistant Professor, Department of Pediatrics, Division of Hematology-Oncology and Blood and Marrow Transplantation
March 26, 2013, 12-1 p.m., 450 MCRB
Targeting cancer stem cells and APOBEC3 enzymes with reactive small molecules
Daniel Harki, Ph.D., Assistant Professor, Department of Medicinal Chemistry, University of Minnesota
See the Cancer Center Seminar calendar to see future seminars and to watch recorded seminars.
Members in the news
A transcript of the interview that John Kersey, M.D., gave to the Academic Health Center’s Oral History Project in available online.
The University of Minnesota Amplatz Children’s Hospital was featured in an Orlando Sentinel story about the Kidz1stFund, organized by Florida State football coach Jimbo Fisher and his wife Candi. The fund has raised $1 million for Fanconi anemia research. The article includes a photo of the family with Margaret MacMillan, M.D., Transplant Biology and Therapy Program member. Read more.
Erin Dickerson, Ph.D., Tumor Microenviroment Program member, wrote an article about nanomedicine's role in cancer prevention for the Academic Health Center’s Health Talk.
Memorial Meeting for Dr. John Kersey to take place Thursday, March 21, 2013
A memorial meeting to celebrate the life of John Kersey, M.D., founding director of the Masonic Cancer Center, will be held at the McNamara Alumni Center, 200 Oak Street SE on Thursday, March 21, 2013 at 6:30 p.m., with a reception at 5 p.m. and immediately following the service. An obituary appeared in the Sunday Star Tribune.
Tumor Microenvironment Program Meeting
Wednesday, March 20, 2013, 9:15-10:15 a.m., 450 MCRB
Targeting the tumor microenvironment to breach drug-free sanctuaries in pancreatic cancer
Paolo Provenzano, Ph.D., Assistant Professor, Department of Biomedical Engineering
Visit the calendar for a schedule of meetings.
BMT Program Meeting
Monday, March 25, 2013, 1:15-2:15 p.m., 450 MCRB
AGVHD doc flow sheet
Visit the calendar for a schedule of meetings.
March 19, 2013: Breast Cancer Journal Club
2-3 p.m., 441 MCRB
Todd Knutson will discuss "Phase II Randomized Study of Trastuzumab Emtansine Versus Trastuzumab Plus Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer," Hurvitz et al. in J Clinical Oncology: 2013 [Epub ahead of print]
March 20, 2013: Cancer Biology Journal Club
12-1 p.m., 6-101 NHH
Jeremy Drees, Saltzman lab, will discuss “Durable Adoptive Immunotherapy for Leukemia Produced by Manipulation of Multiple Regulatory Pathways of CD8 + T-Cell Tolerance,” Berrien-Elliott MM, et al., Cancer Research 2013;73:605.
March 20, 2013: 2013 IMV Innovations in Virus Research Lecture Series
12-1 p.m., 2-520 Moos Tower
The Ancient Origins of Modern Primate Lentiviruses
Michael Emerman, Ph.D., Fred Hutchinson Cancer Research Center
April 11, 2013: University of Minnesota Physicians Cancer Care Service Line Dinner and Workshop
5:30-8 p.m., University Commons Hotel, 615 Washington Avenue SE
Reservations can be made online.
May 23, 2013: Save the Date: Chemical Biology Interface Training Grant Symposium
8:30 a.m.-4:30 p.m.
The symposium will feature scientists from academia and industry speaking on their research at the intersection of chemistry, biology and medicine.
June 19-20, 2013: Cancer Disparities Summit: Moving Communities Towards Change
Sponsors: Minnesota Center for Cancer Collaborations (MC3) and Minnesota Cancer Alliance
The Cancer Disparities Summit will provide participants with a chance to learn about disparities that exist in cancer screening, treatment and mortality, to educate participants about how they can improve cancer prevention, management and survivorship, and to understand how they can participate in initiatives aimed at reducing the cancer disparities throughout Minnesota. One and a half day meeting in Twin Cities with plenary speakers and break-out workshops, poster session, possibly with an evening reception. For more information visit the website.
Registration is now open online.
Visit the Professional Education web page for more conference and special lecture listings.
April 6, 2013: 8th Annual Survivorship Series
8 a.m.-1:30 p.m., McNamara Alumni Center, University of Minnesota, 200 Oak Street SE, Minneapolis, Minn.
This annual conference focuses on questions and issues survivors and their families may face after cancer treatment or following stem cell transplantation. Cancer survivors ages 16 and older, parents, spouses, significant others of cancer survivors, health care professionals, school administrators, and social workers can benefit from this educational conference.
Registration is now open. Click here to register or call 612-624-2620.
Visit the Upcoming Events page for a complete listing of events.
Pancreatic SPORE Competitive Renewal Research Projects RFA (pdf)
Application Deadline: April 18, 2013
Funding: depends on available funds for renewal application; see RFA for additional information
ACS Institutional Research Grant
Application Deadline: April 30, 2013
Funding: $30,000 for 1 year
Applications are being accepted until April 30, 2013. This grant is for assistant professors who have no independent national funding and are engaged in cancer-related research. Cancer-related research includes cancer etiology, mechanisms of carcinogenesis and chemoprevention, molecular mechanisms of cancer progression and metastasis, development of novel cancer therapeutic or chemoprevention models and translational research, cancer immunology and immunotherapy.
This is a one-year seed grant. Funding is available up to $30,000. Applications may be obtained by emailing a request to firstname.lastname@example.org. For information, please call Aaron Schilz, 612-624-0650.
Bioengineering Research Grants (BRG) (R01)
National Cancer Institute
Application Deadline: Multiple receipt dates, see announcement.
Funding: Standard R01 limits apply
A list of organizations that provide funding for cancer research is provided on our Research Funding Resources page.